New department at HZB: ‘AI and Biomolecular Structures’

Since 1 July 2025, Dr. Andrea Thorn has been setting up the new AI and Biomolecular Structures department at HZB.

Since 1 July 2025, Dr. Andrea Thorn has been setting up the new AI and Biomolecular Structures department at HZB. © Cromarte Rogers / Coronavirus Structural Task Force

Since 1 July 2025, Dr. Andrea Thorn has been setting up the new AI and Biomolecular Structures department at HZB. A biophysicist with many years of experience in AI-based tools for structural biology, she is looking forward to collaborating closely with the macromolecular crystallography team at the MX beamlines of BESSY II.


Andrea Thorn completed her PhD in the research group of George Sheldrick at the University of Göttingen and then conducted research as a Marie Curie Fellow in Cambridge on the three-dimensional interactions of large molecules such as proteins and DNA and water. She later moved to Oxford, where she developed the AUSPEX software for analysing diffraction data at the Diamond Light Source. Until recently, she led a group at the Centre for Ultrafast Imaging (CUI) in Hamburg.

During the pandemic, Thorn established the Coronavirus Structural Task Force, an international team that reviewed every new molecular structure of the virus and combined information on these structures from around the world. This enabled the group not only to paint a picture of the virus's molecular biology, but also to map the course of infection and to create the most accurate 3D model of the virus. ‘On this basis, I would like to develop a pipeline at HZB that will allow us to do the same for other diseases, such as influenza. We could partially automate what we have done with 27 specialists in two years for coronavirus. Such a pipeline would allow us not only to design better drugs on the computer ('in silico'), but also to create something like ChatGPT for molecules: a neural network that combines information from different sources and presents it in a meaningful way.'

Thorn is considered an expert in the use of AI-based analysis tools for the experimental measurement and quality assurance of three-dimensional molecular structures. Her group is known for both developing software and conducting experimental work in the laboratory. In addition to viruses and crystallography, the group is also active in cryo-electron microscopy, accident analysis and fungal biology.

In the newly established department, they will further develop computational methods to evaluate data from BESSY II and combine it with other information. Thorn places great importance on making AI-generated analysis results understandable and comprehensible (‘explainable AI’). The new ‘AI and Biomolecular Structures’ department is part of the Photon Science division and expands the possibilities of macromolecular crystallography at BESSY II through AI-based methods.

 

arö

  • Copy link

You might also be interested in

  • Welcome: Apprenticeships begin for 16 young people at HZB
    News
    03.09.2025
    Welcome: Apprenticeships begin for 16 young people at HZB
    On 1 September, 16 young people began their apprenticeship, dual study programme or voluntary year at HZB. A welcome event, initial insights into the world of research and a communication seminar marked the start of this new phase in their lives.
  • Saskia Vormfelde appointed new Administrative Director at HZB
    News
    01.09.2025
    Saskia Vormfelde appointed new Administrative Director at HZB
    Saskia Vormfelde begins her term of office as Administrative Director at HZB on 1 September. She is moving from Freiburg ISE to Berlin.

  • 5000th patient treated with protons for eye tumours
    News
    19.08.2025
    5000th patient treated with protons for eye tumours
    For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.